Insights

Why ALS, Costa, Fisher & Paykel Healthcare, & Ramsay shares are falling

Costa Group Holdings Ltd (ASX:CGC) and Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) and these ASX shares are dropping on Thursday…
The post Why ALS, Costa, Fisher & Paykel Healthcare, & Ramsay shares are falling appeared first on The Motley Fool Australia. –

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has overcome a soft start and is pushing higher. At the time of writing, the benchmark index is up 0.25% to 7,109.8 points.

Four ASX shares that have failed to follow the market higher today are listed below. Here’s why they are falling:

ALS Ltd (ASX: ALQ)

The ALS share price is down 1.5% to $12.08. This decline appears to have been driven by a broker note out of Morgans this morning. According to the note, the broker has downgraded the testing services company’s shares to a hold rating with an $11.56 price target. This was made largely on valuation grounds after a strong rise.

Costa Group Holdings Ltd (ASX: CGC)

The Costa share price has crashed 22% to $3.48 following the release of its annual general meeting update. The horticulture company revealed that it is only expecting its first half performance to be marginally ahead of the prior corresponding period. This is being driven by weakness in its domestic operations and currency headwinds.

Fisher & Paykel Healthcare Corp Ltd (ASX: FPH)

The Fisher & Paykel Healthcare share price has fallen 5.5% to $28.04. Investors have been selling the medical device company’s shares following the release of its full year results. Although the company reported a 56% increase in operating revenue to NZ$1.97 billion and an 82% jump in net profit after tax to NZ$524 million, its outlook appears to have spooked investors. Management warned that things were too uncertain to provide guidance.

Ramsay Health Care Limited (ASX: RHC)

The Ramsay Health Care share price is down 2.5% to $62.81. Investors have been selling the private hospital operator’s shares following the announcement of plans to acquire UK-based Spire Healthcare for approximately 1 billion pounds (A$1,822 million). Management expects the acquisition to be transformational for its UK business. Citi has responded by holding firm with its neutral rating and $67.00 price target. The broker appears uncertain whether it will achieve the synergies it is targeting.

Learn where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be thefive best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of May 24th 2021

More reading

ASX 200 flat: Costa crashes & Fisher & Paykel Healthcare tumbles

Costa (ASX:CGC) share price crashes 23% on AGM update
Fisher & Paykel Healthcare (ASX:FPH) share price on watch after reporting huge profit growth
5 things to watch on the ASX 200 on Thursday

Ramsay Health Care (ASX:RHC) share price on watch after announcing major UK acquisition

The post Why ALS, Costa, Fisher & Paykel Healthcare, & Ramsay shares are falling appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!